Skip to main content

Peer Review reports

From: Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study

Original Submission
26 Jan 2018 Submitted Original manuscript
16 Feb 2018 Author responded Author comments - VASILIKI MICHAEL MAMAKOU
Resubmission - Version 2
16 Feb 2018 Submitted Manuscript version 2
23 May 2018 Author responded Author comments - VASILIKI MICHAEL MAMAKOU
28 Mar 2018 Reviewed Reviewer Report - Markku Lahteenvuo
8 Apr 2018 Reviewed Reviewer Report - Yongyong Shi
Resubmission - Version 3
23 May 2018 Submitted Manuscript version 3
16 Jul 2018 Author responded Author comments - VASILIKI MICHAEL MAMAKOU
5 Jun 2018 Reviewed Reviewer Report - Markku Lahteenvuo
19 Jun 2018 Reviewed Reviewer Report - Yongyong Shi
Resubmission - Version 4
16 Jul 2018 Submitted Manuscript version 4
Publishing
23 Jul 2018 Editorially accepted
2 Aug 2018 Article published 10.1186/s12888-018-1826-4

You can find further information about peer review here.

Back to article page
\